Insights gained from regression analysis of PpIX fluorescence imaging undertaken during routine dermatological photodynamic therapy

Jess Tyrrell; Cheryl Paterson; Alison Curnow

doi:10.1117/12.2525727

7 August 2019 Insights gained from regression analysis of PpIX fluorescence imaging undertaken during routine dermatological photodynamic therapy

Jess Tyrrell, Cheryl Paterson, Alison Curnow

Author Affiliations +

Proceedings Volume 11070, 17th International Photodynamic Association World Congress; 110702Y (2019) https://doi.org/10.1117/12.2525727
Event: 17th International Photodynamic Association World Congress, 2019, Cambridge, Massachusetts, United States

Abstract

Clinical protoporphyrin IX (PpIX) fluorescence imaging was conducted using a pre-validated, non-invasive imaging system (Dyaderm, Biocam, Germany) during routine methyl aminolevulinate (MAL)-PDT treatment of 172 patients with licensed dermatological indications (37.2% actinic keratosis, 27.3% superficial basal cell carcinoma and 35.5% Bowen’s disease). Linear and logistic regressions were employed to model any relationships between variables that may have affected PpIX accumulation and/or PpIX photobleaching during irradiation and thus clinical outcome at three months. Patient age was found to be associated with lower PpIX accumulation and photobleaching, however only a reduction in PpIX photobleaching appeared to consistently adversely affect treatment efficacy. Clinical clearance was reduced in lesions located on the limbs, hands and feet with lower PpIX accumulation and subsequent photobleaching adversely affecting the outcome achieved (OR: 0.5 (0.2, 0.9; p<0.05). If air cooling pain relief was employed during light irradiation, PpIX photobleaching was significantly reduced (p < 0.05) and this resulted in an approximate three-fold reduction in the likelihood of achieving clinical clearance (OR: 0.4 (0.2, 0.7; p<0.01). PpIX accumulation and photobleaching are therefore concluded to be important indicators of dermatological MAL-PDT treatment success and anything that adversely effects them has the potential to reduce treatment efficacy. PpIX photobleaching during the first treatment was found to be an excellent predictor of clinical outcome across all lesion types and non-invasive imaging of PpIX fluorescence during MAL-PDT continues to provide important treatment insights that can be utilised to improve treatment protocols and thus clinical outcomes.

Conference Presentation

Citation Download Citation

Jess Tyrrell, Cheryl Paterson, and Alison Curnow "Insights gained from regression analysis of PpIX fluorescence imaging undertaken during routine dermatological photodynamic therapy", Proc. SPIE 11070, 17th International Photodynamic Association World Congress, 110702Y (7 August 2019); https://doi.org/10.1117/12.2525727

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available